EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.10, sa.10, ss.827-829, 1998 (SCI-Expanded)
Background An increased tendency for thromboembolism is a well known problem of inflammatory bowel disease (IBD). Microvascular thrombosis has also been claimed as a pathogenic factor in IBD. Recently a point mutation in the gene coding factor V (FV Leiden) has been identified in various thromboembolic diseases, but the role in IBD is unknown.